A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

NCT07260110 · clinicaltrials.gov ↗
RECRUITING
Status
550
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi